secwatch.observer — SEC 8-K summary
======================================

Issuer:     Stereotaxis, Inc. (STXS)
CIK:        0001289340
Form:       8-K
Filed at:   2025-03-03T23:59:59+00:00
Accession:  0001493152-25-008810
Event type: earnings
Sentiment:  positive
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Q4 revenue up 39% to $6.3M; expects double-digit revenue growth in 2025
-----------------------------------------------------------------------

- Q4 2024 revenue $6.3M (+39% YoY); full year $26.9M (+0.4% YoY).
- Operating loss ($7.6M) in Q4; adjusted operating loss ($4.0M); net loss ($7.5M).
- Cash $12.4M, no debt; positive free cash flow of $1.3M in Q4.
- 2025 guidance: double-digit revenue growth; recurring revenue to scale from $5M Q1 to $7M Q4.
- Regulatory milestones: European MAGiC catheter approval, GenesisX first sale, China approvals.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1289340/000149315225008810/0001493152-25-008810-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1289340/000149315225008810/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-008810

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer